Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
The continuing evolution of treatment options in thoracic oncology requires the pathologist to
regularly update diagnostic algorithms for management of tumor samples. It is essential to …
regularly update diagnostic algorithms for management of tumor samples. It is essential to …
c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series
C Bontoux, V Hofman, M Abboute… - Journal of Clinical …, 2023 - jcp.bmj.com
Aims Recent clinical trials have shown promising results with drugs targeting the hepatocyte
growth factor receptor (c-Met) for advanced non-small cell lung cancers overexpressing c …
growth factor receptor (c-Met) for advanced non-small cell lung cancers overexpressing c …
L'immunohistochimie c-Met en oncologie thoracique, un nouvel enjeu pour le pathologiste
V Hofman, C Bontoux, S Goffinet, F Murcy… - Revue Francophone des …, 2023 - Elsevier
Résumé Le développement croissant des anticorps conjugués à des molécules
cytotoxiques (ADCs pour Antibody drug conjugates) comme nouvelle stratégie …
cytotoxiques (ADCs pour Antibody drug conjugates) comme nouvelle stratégie …